Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Dermatosis Papulosa Nigra : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Follow-up
Miscellaneous
References

Related Articles
Nevi, Melanocytic

Seborrheic Keratosis




Patient Education
Click here for patient education.



Author: Mehran Nowfar-Rad, MD, Assistant Clinical Professor, Division of Dermatology, David Geffen School of Medicine University California at Los Angeles

Mehran Nowfar-Rad is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, and American Medical Association

Coauthor(s): Frederick Fish, MD, Director, Department of Dermatology and Cutaneous Surgery, St Paul Ramsey Medical Center; Associate Clinical Professor, Department of Dermatology, University of Minnesota

Editors: Kathryn Schwarzenberger, MD, Associate Professor of Medicine, Division of Dermatology, University of Vermont College of Medicine; Consulting Staff, Division of Dermatology, Fletcher Allen Health Care; Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center; Edward F Chan, MD, Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University; Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center

Author and Editor Disclosure

Synonyms and related keywords: DPN, hyperpigmented papules, facial papules, seborrheic keratosis

Background

Dermatosis papulosa nigra (DPN) is a benign cutaneous condition common among blacks. It is usually characterized by multiple, small, hyperpigmented, asymptomatic papules on the face of adult blacks. Histologically, DPN resembles seborrheic keratoses. The condition may be cosmetically undesirable to some patients.

Pathophysiology

The pathophysiology of DPN is not known. The occasional positive family history may suggest a genetic propensity.

Frequency

United States

Whereas earlier studies revealed a 10% frequency in adult blacks, more recent data suggest a frequency of approximately 35% in this population.

International

Data pertaining to the international frequency of DPN are insufficient.

Mortality/Morbidity

DPN is not associated with any mortality or morbidity.

Race

DPN affects up to 35% of the African American population. Blacks with a fair complexion have the lowest frequency of involvement. DPN also occurs among Asians, although the exact incidence is unknown.

Sex

Females are affected more frequently than males.

Age

DPN usually begins in adolescence and is rare under the age of 7 years. The incidence of DPN, as well as the number and size of individual lesions, increases with age.



History

Lesions usually begin during puberty. They tend to increase steadily in number and size as the individual ages.

Physical

DPN is characterized by multiple, firm, smooth, dark brown to black, flattened papules that measure 1-5 mm in diameter. Lesions occur mainly on the malar area of the face and the forehead, although they also may be found on the neck, upper back, and chest. A small percentage of patients have similar lesions on the upper trunk. Scaling, crusting, and ulceration do not occur.

Causes

DPN is likely to be genetically determined, with 40-54% of patients having a family history of involvement. DPN is believed to be caused by a nevoid developmental defect of the pilosebaceous follicle. Hairston et al have suggested that DPN should be classified within the group of epithelial nevi.



Nevi, Melanocytic
Seborrheic Keratosis

Other Problems to be Considered

Acrochordons
Adenoma sebaceum



Histologic Findings

Lesions of DPN have the histologic appearance of seborrheic keratoses; they display hyperkeratosis, irregular acanthosis, keratin-filled invaginations of the epidermis (horn cysts), and marked hyperpigmentation of the basal layer. Although most lesions are of the acanthotic type and show thick interwoven tracts of epidermal cells, they may have a reticulated pattern in which the tracts consist of a double row of basaloid cells.



Surgical Care

No treatment generally is indicated for DPN unless lesions are cosmetically undesirable. Aggressive therapeutic modalities have been complicated by postoperative hyperpigmentation or hypopigmentation or scarring. Keloid formation is a potential complication. Therefore, conservative treatment is advisable.

Abrasive curettage with or without anesthesia, superficial liquid nitrogen cryotherapy, and electrodesiccation followed by curettage have been shown to be effective. Both EMLA (topical lidocaine/prilocaine cream) and LMX (topical lidocaine cream) creams are effective for providing topical anesthesia. Use caution with all therapies to minimize the depth of treatment.



Prognosis

  • The prognosis for patients with DPN is excellent since it is not a premalignant condition nor is it associated with any underlying systemic disease. However, lesions of DPN show no tendency to regress spontaneously, and they gradually may increase in number and size with age.



Medical/Legal Pitfalls

  • DPN is generally a clinical diagnosis and is only rarely confused with melanocytic lesions. A skin biopsy would be helpful in such cases.



  • Andrews GC et al. Andrews' Diseases of the Skin. 8th ed. 8th ed. Philadelphia, Pa: WB Saunders; 1990:. 752.
  • Babapour R, Leach J, Levy J. Dermatosis papulosa nigra in a young child. Ped Dermatol. 1993;10(4):356-358. [Medline].
  • Carter EL, Coppola CA, Barsanti FA. A randomized, double-blind comparison of two topical anesthetic formulations prior to electrodesiccation of dermatosis papulosa nigra. Dermatol Surg. Jan 2006;32(1):1-6. [Medline].
  • Dunwell P, Rose A. Study of the skin disease spectrum occurring in an Afro-Caribbean population. Int J Dermatol. Apr 2003;42(4):287-9. [Medline].
  • Elder D et al. Lever's Histopathology of the Skin. 8th ed. Philadelphia, Pa: Lippincott-Raven. 1997;693.
  • Grimes PE, Arora S, Minus HR, Kenney JA Jr. Dermatosis papulosa nigra. Cutis. Oct 1983;32(4):385-6, 392. [Medline].
  • Hairston MA Jr, Reed RJ, Derbes VJ. Dermatosis papulosa nigra. Arch Dermatol. May 1964;89:655-8. [Medline].
  • Kauh YC, McDonald JW, Rapaport JA, et al. A surgical approach for dermatosis papulosa nigra. Int J Dermatol. Dec 1983;22(10):590-2. [Medline].
  • Moschella SL, Hurley HJ. Dermatology. Philadelphia, Pa: WB Saunders. 1992;2162-3.
  • Rook A, Wilkinson DS, Ebling FJG. Textbook of Dermatology. Vol 2. Oxford, England: Blackwell Scientific. 1998;1660-1.

Dermatosis Papulosa Nigra excerpt

Article Last Updated: Dec 4, 2006